Utama › Sklerosis Pelbagai › Tennessee
Kajian klinikal Sklerosis Pelbagai di Tennessee
6 kajian untuk Sklerosis Pelbagai sedang mencari peserta di lokasi di Tennessee.
Bandar di Tennessee
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Hope Neurology, Knoxville
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06782490A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Neurology Clinic PC, Cordova
Mengambil pesertaFasa 4
Umur 18 hingga 65 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07609719A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Franklin
- TG Therapeutics Investigational Trial Site, Knoxville
- TG Therapeutics Investigational Trial Site, Mount Juliet
- dan 2 lagi
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06433752RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Alliance for Multispecialty Research Clinical, Knoxville
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Hope Neurology- Site Number : 8400019, Knoxville
Mengambil pesertaFasa 3
Umur 18 hingga 60 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07325292A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Neurology Clinic PC, Cordova
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT07225504Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.